Asepxia Acne Treatment

Description

Asepxia® is an acne treatment cream formulated with 2% salicylic acid, designed to eliminate most pimples and blackheads. The product is presented in a net weight of 1 ounce (28 grams).

Uses and Indications

This drug is indicated for the treatment of acne. It effectively dries and clears acne blemishes while penetrating pores to eliminate most existing acne lesions. Additionally, it helps prevent the formation of new acne blemishes.

There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer, which may be done one to three times daily.

To minimize the risk of excessive drying of the skin, it is advisable to initiate treatment with one application per day. Based on the patient's response, the frequency may be gradually increased to two or three times daily, as needed or as directed by a physician.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day. Should any irritation or sensitivity develop, the use of the product should be discontinued, and a healthcare provider should be consulted.

For new users, a sensitivity test is recommended. This involves applying the product sparingly to one or two small affected areas during the first three days of use. If no discomfort is experienced, the user may then proceed to follow the previously mentioned application guidelines.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation occurs, it is recommended to limit the use to one topical acne treatment at a time to mitigate adverse effects.

It is imperative to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if they are concurrently using another topical acne medication. It is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. This product is intended for external use only, and caution should be exercised to prevent ingestion.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advisable to limit the use to one topical acne medication at a time. If irritation occurs, the patient should discontinue the use of additional topical agents and focus on a single treatment to allow the skin to recover. Monitoring for signs of irritation is recommended to ensure patient comfort and treatment adherence.

Packaging & NDC

Below are the non-prescription pack sizes of Asepxia Acne Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For pediatric patients experiencing bothersome dryness or peeling, it is recommended to reduce the frequency of application to once daily or every other day. Should any irritation or sensitivity occur, the use of the product should be discontinued, and a healthcare professional should be consulted.

Geriatric Use

There is no specific information regarding the use of Asepxia Acne Treatment Cream in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this treatment to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of Asepxia Acne Treatment Cream during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no known safety concerns, dosage modifications, or special precautions outlined for this population. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable for pregnant patients to consult their healthcare provider before using Asepxia Acne Treatment Cream.

Lactation

There are no specific warnings or recommendations regarding the use of Asepxia Acne Treatment Cream in lactating mothers. Additionally, there is no information available about the potential for excretion of the product in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of seeking immediate medical assistance or contacting a Poison Control Center if the medication is swallowed. This information is vital for ensuring patient safety and preventing potential harm.

Storage and Handling

The product is supplied in a tightly closed container to maintain its integrity. It should be stored at room temperature to ensure optimal stability and efficacy. Proper handling is essential to prevent contamination and preserve the quality of the product.

Additional Clinical Information

The product is administered topically. Clinicians should advise patients that if irritation occurs, they should limit the use to one topical acne medication at a time. In cases of bothersome dryness or peeling, patients may reduce the application frequency to once daily or every other day. New users are recommended to perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days; if no discomfort arises, they can proceed with the standard application instructions.

Drug Information (PDF)

This file contains official product information for Asepxia Acne Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)